health π¬ Caffeine metabolite might slow kids' nearsightedness
Researchers are exploring 7-methylxanthine (7-MX) as a potential treatment to slow down childhood myopia progression. The study focuses on how 7-MX targets scleral remodeling and axial elongation in children. A 36-month pilot study involving 68 myopic children showed reduced axial growth with no adverse effects reported. This drug acts by promoting structural reinforcement in the eye's back, stimulating collagen production. The findings suggest 7-MX could complement current myopia control strategies for better long-term eye health. π¬